These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36695684)

  • 1. Demographic and Clinical Characteristics of Mpox in Persons Who Had Previously Received 1 Dose of JYNNEOS Vaccine and in Unvaccinated Persons - 29 U.S. Jurisdictions, May 22-September 3, 2022.
    Farrar JL; Lewis NM; Houck K; Canning M; Fothergill A; Payne AB; Cohen AL; Vance J; Brassil B; Youngkin E; Glenn B; Mangla A; Kupferman N; Saunders K; Meza C; Nims D; Soliva S; Blouse B; Henderson T; Banerjee E; White B; Birn R; Stadelman AM; Abrego M; McLafferty M; Eberhart MG; Pietrowski M; De León SM; Creegan E; Diedhiou A; Wiedeman C; Murray-Thompson J; McCarty E; Marcinkevage J; Kocharian A; Torrone EA; Ray LC; Payne DC;
    Am J Transplant; 2023 Feb; 23(2):298-303. PubMed ID: 36695684
    [No Abstract]   [Full Text] [Related]  

  • 2. Demographic and Clinical Characteristics of Mpox in Persons Who Had Previously Received 1 Dose of JYNNEOS Vaccine and in Unvaccinated Persons - 29 U.S. Jurisdictions, May 22-September 3, 2022.
    Farrar JL; Lewis NM; Houck K; Canning M; Fothergill A; Payne AB; Cohen AL; Vance J; Brassil B; Youngkin E; Glenn B; Mangla A; Kupferman N; Saunders K; Meza C; Nims D; Soliva S; Blouse B; Henderson T; Banerjee E; White B; Birn R; Stadelman AM; Abrego M; McLafferty M; Eberhart MG; Pietrowski M; De León SM; Creegan E; Diedhiou A; Wiedeman C; Murray-Thompson J; McCarty E; Marcinkevage J; Kocharian A; Torrone EA; Ray LC; Payne DC;
    MMWR Morb Mortal Wkly Rep; 2022 Dec; 71(5152):1610-1615. PubMed ID: 36580416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons - 43 U.S. Jurisdictions, July 31-October 1, 2022.
    Payne AB; Ray LC; Cole MM; Canning M; Houck K; Shah HJ; Farrar JL; Lewis NM; Fothergill A; White EB; Feldstein LR; Roper LE; Lee F; Kriss JL; Sims E; Spicknall IH; Nakazawa Y; Gundlapalli AV; Shimabukuro T; Cohen AL; Honein MA; Mermin J; Payne DC
    MMWR Morb Mortal Wkly Rep; 2022 Dec; 71(49):1560-1564. PubMed ID: 36480479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of Monkeypox Among Unvaccinated Persons Compared with Persons Receiving ≥1 JYNNEOS Vaccine Dose - 32 U.S. Jurisdictions, July 31-September 3, 2022.
    Payne AB; Ray LC; Kugeler KJ; Fothergill A; White EB; Canning M; Farrar JL; Feldstein LR; Gundlapalli AV; Houck K; Kriss JL; Lewis NM; Sims E; Smith DK; Spicknall IH; Nakazawa Y; Damon IK; Cohn AC; Payne DC
    MMWR Morb Mortal Wkly Rep; 2022 Oct; 71(40):1278-1282. PubMed ID: 36201401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of JYNNEOS Vaccine Against Diagnosed Mpox Infection - New York, 2022.
    Rosenberg ES; Dorabawila V; Hart-Malloy R; Anderson BJ; Miranda W; O'Donnell T; Gonzalez CJ; Abrego M; DelBarba C; Tice CJ; McGarry C; Mitchell EC; Boulais M; Backenson B; Kharfen M; McDonald J; Bauer UE
    MMWR Morb Mortal Wkly Rep; 2023 May; 72(20):559-563. PubMed ID: 37339074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receipt of First and Second Doses of JYNNEOS Vaccine for Prevention of Monkeypox - United States, May 22-October 10, 2022.
    Kriss JL; Boersma PM; Martin E; Reed K; Adjemian J; Smith N; Carter RJ; Tan KR; Srinivasan A; McGarvey S; McGehee J; Henderson D; Aleshire N; Gundlapalli AV
    MMWR Morb Mortal Wkly Rep; 2022 Oct; 71(43):1374-1378. PubMed ID: 36301741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study - United States, August 19, 2022-March 31, 2023.
    Dalton AF; Diallo AO; Chard AN; Moulia DL; Deputy NP; Fothergill A; Kracalik I; Wegner CW; Markus TM; Pathela P; Still WL; Hawkins S; Mangla AT; Ravi N; Licherdell E; Britton A; Lynfield R; Sutton M; Hansen AP; Betancourt GS; Rowlands JV; Chai SJ; Fisher R; Danza P; Farley M; Zipprich J; Prahl G; Wendel KA; Niccolai L; Castilho JL; Payne DC; Cohn AC; Feldstein LR; ;
    MMWR Morb Mortal Wkly Rep; 2023 May; 72(20):553-558. PubMed ID: 37200229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety Monitoring of JYNNEOS Vaccine During the 2022 Mpox Outbreak - United States, May 22-October 21, 2022.
    Duffy J; Marquez P; Moro P; Weintraub E; Yu Y; Boersma P; Donahue JG; Glanz JM; Goddard K; Hambidge SJ; Lewin B; Lewis N; Rouse D; Shimabukuro T
    MMWR Morb Mortal Wkly Rep; 2022 Dec; 71(49):1555-1559. PubMed ID: 36480476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JYNNEOS Vaccination Coverage Among Persons at Risk for Mpox - United States, May 22, 2022-January 31, 2023.
    Owens LE; Currie DW; Kramarow EA; Siddique S; Swanson M; Carter RJ; Kriss JL; Boersma PM; Lee FC; Spicknall I; Hurley E; Zlotorzynska M; Gundlapalli AV
    MMWR Morb Mortal Wkly Rep; 2023 Mar; 72(13):342-347. PubMed ID: 36995962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JYNNEOS Vaccine for Mpox.
    Desai AN; Malani PN
    JAMA; 2023 Jun; 329(22):1995. PubMed ID: 37314274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced Odds of Mpox-Associated Hospitalization Among Persons Who Received JYNNEOS Vaccine - California, May 2022-May 2023.
    Schildhauer S; Saadeh K; Vance J; Quint J; Salih T; Lo T; Keinde A; Chojolan E; Gotlieb E; Ramos M; Chapman E; Peters P; Watson J; Johnson KA; Tang EC; Jacobson K; Snyder RE
    MMWR Morb Mortal Wkly Rep; 2023 Sep; 72(36):992-996. PubMed ID: 37676838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac events following JYNNEOS vaccination for prevention of Mpox.
    Sharff KA; Tandy TK; Lewis PF; Johnson ES
    Vaccine; 2023 May; 41(22):3410-3412. PubMed ID: 37117055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of Congo.
    Priyamvada L; Carson WC; Ortega E; Navarra T; Tran S; Smith TG; Pukuta E; Muyamuna E; Kabamba J; Nguete BU; Likafi T; Kokola G; Lushima RS; Tamfum JM; Okitolonda EW; Kaba DK; Monroe BP; McCollum AM; Petersen BW; Satheshkumar PS; Townsend MB
    Vaccine; 2022 Nov; 40(50):7321-7327. PubMed ID: 36344361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythema and Induration after Mpox (JYNNEOS) Vaccination Revisited.
    Frey SE; Goll JB; Beigel JH
    N Engl J Med; 2023 Apr; 388(15):1432-1435. PubMed ID: 36947462
    [No Abstract]   [Full Text] [Related]  

  • 15. Real-world effectiveness of a single dose of mpox vaccine in males.
    Wolff Sagy Y; Zucker R; Hammerman A; Markovits H; Arieh NG; Abu Ahmad W; Battat E; Ramot N; Carmeli G; Mark-Amir A; Wagner-Kolasko G; Duskin-Bitan H; Yaron S; Peretz A; Arbel R; Lavie G; Netzer D
    Nat Med; 2023 Mar; 29(3):748-752. PubMed ID: 36720271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monkeypox-induced immunity and failure of childhood smallpox vaccination to provide complete protection.
    Karem KL; Reynolds M; Hughes C; Braden Z; Nigam P; Crotty S; Glidewell J; Ahmed R; Amara R; Damon IK
    Clin Vaccine Immunol; 2007 Oct; 14(10):1318-27. PubMed ID: 17715329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demographic Disparities in Mpox Vaccination Series Completion, by Route of Vaccine Administration - California, August 9, 2022-March 31, 2023.
    Salih T; Vance J; Quint J; Meza B; McNitt L; Lincoln WU; Schechter R
    MMWR Morb Mortal Wkly Rep; 2023 Jul; 72(30):827-832. PubMed ID: 37498796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible Mpox Protection from Smallpox Vaccine-Generated Antibodies among Older Adults.
    Sanz-Muñoz I; Sánchez-dePrada L; Sánchez-Martínez J; Rojo-Rello S; Domínguez-Gil M; Hernán-García C; Fernández-Espinilla V; de Lejarazu-Leonardo RO; Castrodeza-Sanz J; Eiros JM
    Emerg Infect Dis; 2023 Mar; 29(3):656-658. PubMed ID: 36732061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mpox vaccination willingness, determinants, and communication needs in gay, bisexual, and other men who have sex with men, in the context of limited vaccine availability in the Netherlands (Dutch Mpox-survey).
    Dukers-Muijrers NHTM; Evers Y; Widdershoven V; Davidovich U; Adam PCG; Op de Coul ELM; Zantkuijl P; Matser A; Prins M; de Vries HJC; den Heijer C; Hoebe CJPA; Niekamp AM; Schneider F; Reyes-Urueña J; Croci R; D'Ambrosio A; van der Valk M; Posthouwer D; Ackens R; Ter Waarbeek H; Noori T; Hoornenborg E
    Front Public Health; 2022; 10():1058807. PubMed ID: 36684959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monkeypox Virus Infections After 2 Preexposure Doses of JYNNEOS Vaccine - United States, May 2022-May 2024.
    Guagliardo SAJ; Kracalik I; Carter RJ; Braden C; Free R; Hamal M; Tuttle A; McCollum AM; Rao AK
    MMWR Morb Mortal Wkly Rep; 2024 May; 73(20):460-466. PubMed ID: 38781111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.